Cincinnati, Ohio and Guangzhou, China: July 31, 2018. CUBD has added Sense Diagnostics an early stage medical technology company spawned from technology developed at the University of Cincinnati, who has developed a non-invasive, disposable device that continuously monitors brain activity primarily in the intensive care unit to their list of clients. CUBD will work with the Sense team to license their technology and expand their distribution in China. Sense CEO Dan Kincaid will also present at the China Medical Innovation Forum in Suzhou China September 6-9, 2018.
About Sense Diagnostics:
Sense has developed a non-invasive radiofrequency (RF) sensor that detects changes in the brain including Hemorrhage/bleeding, Brain swelling (cerebral edema) and Seizures.The Sense device transmits a low power tailored electromagnetic (EM) pulse in the RF range across the patient’s brain and detects changes in the signal that may indicate acute hemorrhage, brain swelling, or seizure. The device consists of three parts: (1) an antenna array, (2) the driving electronics for the array, and (3) a spectrum analyzer coupled with a computer that analyzes the EM signals and detects changes in brain status.